• NICE NG28 Type 2 diabetes in adults: management
• NICE NG17 Type 1 diabetes in adults: diagnosis and management
• NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management
• Medication for fertility treatment - guidance for primary care prescribers
• NHS Kernow updated guidance for prescribing of SGLT2 inhibitors May 2022
• Glucagon-like peptide-1 (GLP-1) analogue factsheet 2022
• Information for people with questions about the availability of the new medicine Wegovy® (semaglutide)
• Semaglutide (Ozempic) setting pre-set quantities in GP practice systems to prevent overprescribing
• Guidelines for Blood Glucose Monitoring in Adults 2024
  

The use of all preparations in section 6.5 requires detailed prior investigation and should be reserved for specialist centres.

Tetracosactide test - consult relevant endocrine / clinical chemistry protocol.

IVF is currently available to NHS patients in Cornwall & IoS who meet defined criteria. All prescribing will be undertaken by the specialist units.

Guidance on human growth hormone (somatropin) in adults with growth hormone deficiency was issued by NICE in August 2003.

Guidance on the use of human growth hormone (somatropin) in children with growth failure was issued by NICE in May 2002.